Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human SDNSF/MCFD2 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB2357
This item is not returnable.
View return policy
Description
SDNSF/MCFD2 Monoclonal specifically detects SDNSF/MCFD2 in Human samples. It is validated for Western Blot, Immunohistochemistry.Specifications
SDNSF/MCFD2 | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL | |
Q8NI22 | |
MCFD2 | |
E. coli-derived recombinant human SDNSF/MCFD2 Glu27-Gln146 Accession # Q8NI22 | |
100 μg | |
Primary | |
Detects human SDNSF/MCFD2 in direct ELISAs and Western blots. In direct ELISAs, approximately 25% cross-reactivity with recombinant mouse SDNSF is observed. In Western blots, no cross-reactivity with recombinant mouse SDNSF is observed. | |
Human | |
Purified |
Western Blot, Immunohistochemistry | |
294301 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
DKFZp686G21263, F5F8D2, LMAN1IP, MCFD2, multiple coagulation factor deficiency 2, multiple coagulation factor deficiency protein 2, neural stem cell derived neuronal survival protein, Neural stem cell-derived neuronal survival protein, SDNSFF5F8D | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
90411 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction